Split Opinions on Training Strategies
PharmaTech
FEBRUARY 9, 2025
Survey results show that being intellectually stimulated and getting assigned challenging projects are two key drivers of employee satisfaction, yet job training is lacking.
Sun.Feb 09, 2025
52 
Machine Learning Shows Promise Predicting Progression of CKD to Kidney Failure
Pharmacy Times
FEBRUARY 9, 2025
These findings can lay the foundation for the development of machine learning models in chronic kidney disease (CKD) and kidney failure.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond
MedCity News
FEBRUARY 9, 2025
At a moment when medication therapy for sickle cell disease (SCD) leaves too many behind and widespread access to curative gene therapies still lies in the distant future, automated red blood cell exchange is experiencing renewed interest. To improve patients lives, a broad commitment is needed to expand access to transfusion therapies. The post Beyond Drugs: Blood-Based Therapies in Sickle Cell Disease and Beyond appeared first on MedCity News.
Pharmacists Play Pivotal Roles in Outpatient CAR T-Cell Therapy
Pharmacy Times
FEBRUARY 9, 2025
Molly Schiffer, PharmD, BCOP, discusses the logistical and operational challenges of delivering outpatient CAR T-cell therapy, emphasizing the benefits of outpatient treatment, including reduced costs, improved access to therapy, and better quality of life for patients.
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline
MedCity News
FEBRUARY 9, 2025
Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex Pharmaceuticals product Trikafta. The biotech has three internally developed programs that hit a target unaddressed by any currently available CF therapies. The post Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline appeared first on MedCity News.
Could the Trump Administration Change the Medicare Drug Price Negotiation Program?
MedCity News
FEBRUARY 9, 2025
CMS recently issued a statement saying that it’s continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see. The post Could the Trump Administration Change the Medicare Drug Price Negotiation Program? appeared first on MedCity News.
Let's personalize your content